Arkolith/Insider Trading/TRAX

TRAX Insider Trading

First Tracks Biotherapeutics, Inc. · full profile →Last filing Jun 15, 2026
Net Buying · 180d
Open-Market Buys (180d)
$65.0M
1 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$65.0M
open market, 180d
Reporting Insiders
1
1 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
Jun 15, 2026Orwin John ADirectorOption exercise(M)6K—$0
Jun 15, 2026Orwin John ADirectorOption exercise(M)6K—$0
Jun 15, 2026Fenton Dennis MDirectorOption exercise(M)6K—$0
Jun 15, 2026Fenton Dennis MDirectorOption exercise(M)6K—$0
Jun 15, 2026Schmid John P.DirectorOption exercise(M)6K—$0
Jun 15, 2026Schmid John P.DirectorOption exercise(M)6K—$0
Jun 15, 2026Marquet MagdaDirectorOption exercise(M)6K—$0
Jun 15, 2026Marquet MagdaDirectorOption exercise(M)6K—$0
Jun 15, 2026Jain RitaDirectorOption exercise(M)7K—$0
Jun 15, 2026Jain RitaDirectorOption exercise(M)6K—$0
Jun 15, 2026Jain RitaDirectorOption exercise(M)1K—$0
Jun 15, 2026Ware J. AnthonyDirectorOption exercise(M)6K—$0
Jun 15, 2026Ware J. AnthonyDirectorOption exercise(M)6K—$0
May 12, 2026Stone BenjaminChief Business OfficerGrant(A)72K—$0
May 12, 2026Stone BenjaminChief Business OfficerGrant(A)27K—$0
May 12, 2026Ware J. AnthonyDirectorGrant(A)42K—$0
May 12, 2026Ware J. AnthonyDirectorGrant(A)15K—$0
May 12, 2026Marquet MagdaDirectorGrant(A)42K—$0
May 12, 2026Marquet MagdaDirectorGrant(A)15K—$0
May 12, 2026Schmid John P.DirectorGrant(A)42K—$0
May 12, 2026Schmid John P.DirectorGrant(A)15K—$0
May 12, 2026Orwin John ADirectorGrant(A)42K—$0
May 12, 2026Orwin John ADirectorGrant(A)15K—$0
May 12, 2026Faga DanielPresident, CEO, DirectorGrant(A)271K—$0
May 12, 2026Faga DanielPresident, CEO, DirectorGrant(A)100K—$0
May 12, 2026Tamboli AjimChief Financial OfficerGrant(A)14K—$0
May 12, 2026Tamboli AjimChief Financial OfficerGrant(A)5K—$0
May 12, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)72K—$0
May 12, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)27K—$0
May 12, 2026Jain RitaDirectorGrant(A)42K—$0
May 12, 2026Jain RitaDirectorGrant(A)15K—$0
May 12, 2026Fenton Dennis MDirectorGrant(A)42K—$0
May 12, 2026Fenton Dennis MDirectorGrant(A)15K—$0
May 12, 2026Jain RitaDirectorGrant(A)3K—$0
May 12, 2026Jain RitaDirectorGrant(A)7K—$0
May 12, 2026Marquet MagdaDirectorGrant(A)3K—$0
May 12, 2026Marquet MagdaDirectorGrant(A)7K—$0
May 12, 2026Orwin John ADirectorGrant(A)3K—$0
May 12, 2026Orwin John ADirectorGrant(A)7K—$0
May 12, 2026Schmid John P.DirectorGrant(A)3K—$0
May 12, 2026Schmid John P.DirectorGrant(A)7K—$0
May 12, 2026Fenton Dennis MDirectorGrant(A)3K—$0
May 12, 2026Fenton Dennis MDirectorGrant(A)7K—$0
May 12, 2026Ware J. AnthonyDirectorGrant(A)3K—$0
May 12, 2026Ware J. AnthonyDirectorGrant(A)7K—$0
Apr 23, 2026Tamboli AjimChief Financial OfficerGrant(A)41K—$0
Apr 22, 2026Tamboli AjimChief Financial OfficerGrant(A)41K—$0
Apr 21, 2026Tamboli AjimChief Financial OfficerGrant(A)41K—$0
Apr 21, 2026Tamboli AjimChief Financial OfficerGrant(A)46K—$0
Apr 20, 2026Jain RitaDirectorGrant(A)4K—$0
Apr 20, 2026Jain RitaDirectorGrant(A)6K—$0
Apr 20, 2026Jain RitaDirectorGrant(A)1K—$0
Apr 20, 2026Jain RitaDirectorGrant(A)6K—$0
Apr 20, 2026Jain RitaDirectorGrant(A)17K—$0
Apr 20, 2026Jain RitaDirectorGrant(A)17K—$0
Apr 20, 2026Jain RitaDirectorGrant(A)8K—$0
Apr 20, 2026Jain RitaDirectorGrant(A)11K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)4K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)6K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)6K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)17K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)17K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)11K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)9K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)11K—$0
Apr 20, 2026Marquet MagdaDirectorGrant(A)784—$0
Apr 20, 2026Schmid John P.DirectorGrant(A)4K—$0
Apr 20, 2026Schmid John P.DirectorGrant(A)6K—$0
Apr 20, 2026Schmid John P.DirectorGrant(A)6K—$0
Apr 20, 2026Schmid John P.DirectorGrant(A)17K—$0
Apr 20, 2026Anaptysbio, Inc10% OwnerOther(J)100——
Apr 20, 2026EcoR1 Capital, LLC10% OwnerBuy(S)4.7M$13.81$65.0M
Apr 20, 2026Fenton Dennis MDirectorGrant(A)6K—$0
Apr 20, 2026Fenton Dennis MDirectorGrant(A)6K—$0
Apr 20, 2026Fenton Dennis MDirectorGrant(A)6K—$0
Apr 20, 2026Fenton Dennis MDirectorGrant(A)11K—$0
Apr 20, 2026Fenton Dennis MDirectorGrant(A)11K—$0
Apr 20, 2026Fenton Dennis MDirectorGrant(A)9K—$0
Apr 20, 2026Fenton Dennis MDirectorGrant(A)11K—$0
Apr 20, 2026Fenton Dennis MDirectorGrant(A)17K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)84K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)45K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)70K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)67K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)116K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)97K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)29K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)6K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)21K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)26K—$0
Apr 20, 2026Lizzul Paul F.Chief Medical OfficerGrant(A)21K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)29K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)11K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)6K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)6K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)11K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)11K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)9K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)11K—$0
Apr 20, 2026Ware J. AnthonyDirectorGrant(A)17K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).